دورية أكاديمية

Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel

التفاصيل البيبلوغرافية
العنوان: Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel
المؤلفون: Facey, Karen M.Aff1, Espin, JaimeAff2, Aff3, Aff4, Kent, Emma, Link, Angèl, Nicod, Elena, O’Leary, Aisling, Xoxi, Entela, van de Vijver, Inneke, Zaremba, Anna, Benisheva, Tatyana, Vagoras, Andrius, Upadhyaya, Sheela
المصدر: PharmacoEconomics. 39(9):1021-1044
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:11707690
11792027
DOI:10.1007/s40273-021-01050-5